Searchable News & Info From Reliable Online Sources.
- Prostate cancer screening only for “a few thousand” high risk men
Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors. [TheTopNews] Read More.3 days ago - Doctors push new blood tests for colon cancer as cases surge in younger adults
The American Cancer Society (ACS) has updated its guidelines for colorectal cancer screening.The organization released the update in its flagship journal on Wednesday, noting that the new recommendations "re-affirm" that adults at average risk should be screened for colorectal cancer at age 45 and continue through 75, for those with a life expectancy greater than 10 years.In addition to the standard colonoscopy, the ACS also recommends that patients receive a blood-based screening test in a doctor’s office, which is designed to detect tumor DNA in the blood.COMMON CANCER TYPE COULD BE DETECTED WITH NEW BLOOD TESTThe ACS also suggested an at-home screening option that looks for hidden blood and molecular markers in stool samples.These new guidelines reflect recent advancements in disease detection, as well as a "critical shift in public health strategy to expand screening options and lower barriers to access," the ACS stated in a press release.Dr. Robert Smith, senior vice president of early cancer detection science at the American Cancer Society and senior author of the report, wrote in a statement that colorectal cancer should be emphasized as a "highly preventable disease as much as a treatable one.""By offering more screening tools in our guideline update, more eligible adults will be able to participate in lifesaving colorectal cancer testing, helping to close the screening gap and catch more cancers at an earlier, treatable stage," he added.JAMES VAN DER BEEK MISTOOK CANCER SYMPTOMS FOR PROBLEMS WITH HIS DIETAccording to the ACS, colorectal screening "dramatically improves survival," as studies show early-stage detection yields a five-year survival rate of more than 90% in the U.S.About one in three American adults are eligible for colorectal cancer screening but have not been tested, although ACS research marks colorectal cancer as the top cancer killer of adults under 50.People at a high risk of colorectal cancer may need to begin screening before age 45 or be screened more often, the ACS added. Those over 85 years old should no longer be screened for colorectal cancer, per the guidelines.Dr. William Dahut, chief scientific officer at the ACS, commented that "no matter which test you choose, what’s most important is to get screened, and that includes underserved, rural and minority populations."CLICK HERE FOR MORE HEALTH STORIESThese guideline changes follow a surge in colorectal cancer diagnoses in younger individuals. Recent ACS research revealed a 50% relative increase in diagnoses in adults aged 45 to 49 from 2021… [TheTopNews] Read More.4 days ago - ER doctor reveals how pneumonia can suddenly turn deadly after Kyle Busch’s de...The sudden death of Kyle Busch has drawn attention to a rare but devastating medical progression: when pneumonia escalates into fatal sepsis.An ER doctor spoke with Fox News Digital about how sepsis can trigger a rapid health decline."Sepsis is actually not a specific disease or diagnosis, but rather the syndrome that occurs when the body has certain abnormal findings and a presumed infection," said Dr. Kenneth J. Perry, a South Carolina-based emergency medicine physician.HOW PNEUMONIA PROGRESSES TO SEPSIS: DOCTORS EXPLAIN AFTER KYLE BUSCH'S DEATHThe markers of sepsis include elevated white blood cell counts, a high or low temperature, and elevated heart and respiratory rates, according to Perry. Because of this, a patient with pneumonia is often already technically septic by definition.While many people assume a worsening infection means bacteria are multiplying uncontrollably, it often has more to do with the body’s internal environment."It is often not the bacteria itself that is causing the specific decline," Perry said. "In most cases, it is a cascade of inflammatory processes that are set in motion by the infection."When this inflammation spirals out of control, the body moves from having a manageable infection into severe sepsis. This is when otherwise healthy people can rapidly deteriorate.SURGE IN WALKING PNEUMONIA AFFECTS THESE HIGH-RISK GROUPS, SAYS DR. MARC SIEGEL"The concerning thing that can happen with any individual ... is that sepsis can then lead to low blood pressure, worsening vital signs and organ damage," Perry said."As multiple organs fail, it becomes very difficult for the medical team to treat and can sometimes lead ultimately to death."It is very unlikely to have pneumonia and not have any symptoms, according to Perry. Early signs can mimic a severe flu, including fevers, chills, a productive cough, and chest or back pain in cases where the lung is infected.When sepsis begins to take hold, time becomes the most critical factor. "We have known for a number of years that early antibiotic therapy is beneficial in the treatment of sepsis," Perry said.CLICK HERE FOR MORE HEALTH STORIESIf you or a loved one are managing an infection at home, the doctor says the following red flags mean you should bypass the clinic and head straight to the emergency room.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERWhile cases like Busch's are tragic, Perry stressed that this shouldn't cause widespread panic. Most patients with pneumonia do very well with standard oral antibiotics.The NASCAR star's… [TheTopNews] Read More.4 days ago
- Sleep doctor reveals the brutal health downside of daylight saving timeThe Trump administration is taking another look at ending biannual clock changes, with an eye toward making daylight saving time (DST), or the "summer clock," permanent.On May 21, the House Energy and Commerce Committee advanced legislation that would make daylight saving time permanent in a 48-1 vote, part of a largely bipartisan push to end twice-yearly clock changes.Although gaining extra winter evening daylight might seem like a win, health experts say permanent daylight saving time could disrupt people's natural circadian rhythms.TRUMP CHAMPIONS BID TO NIX CLOCK CHANGES BY ADOPTING PERMANENT DAYLIGHT SAVING TIMEIn an interview with Fox News Digital, Dr. Wendy Troxel, a licensed clinical psychologist and senior behavioral scientist at RAND based in Utah, said science is being "misconstrued" in this decision."Ending the biannual clock change is something most sleep scientists and the public would welcome," she said. "The disruption of springing forward every March is associated with real, measurable harm — spikes in car crashes, heart attacks and sleep deprivation."However, Troxel noted, implementing permanent daylight saving time is "not supported by science." Instead, evidence "strongly supports" permanent standard time, or the "winter clock," according to the expert.Major sleep medicine organizations, including the American Academy of Sleep Medicine, have previously supported adopting permanent standard time over permanent daylight saving time.HERE'S WHY 90% OF AMERICANS DON'T SLEEP THROUGH THE NIGHT, ACCORDING TO EXPERT"Standard time is more closely aligned with human circadian biology, meaning the relationship between light, darkness and our internal clocks remains intact," Troxel said."Permanent DST simply shifts an hour of morning sunlight to the evening, and there are significant health and safety costs of that trade."The U.S. attempted permanent DST in the early 1970s, but the plan was aborted in part due to these "morning consequences," according to the sleep expert."Within a year, the law was repealed amid public displeasure with commuting to work and school in the dark and increases in morning car crashes, and with no demonstrable impact on energy savings," Troxel told Fox News Digital.Human circadian rhythms are primarily "anchored" by morning light, Troxel said. Under permanent DST, most people waking up for work or school would be rising before the sun, which forces a "chronic misalignment between the body’s internal clock and the external world."FORCING AN EARLY WAKE-UP TIME COULD HARM YOUR HEALTH, SLEEP DOCTORS WARN"You cannot override that biology by simply shifting external clocks forward," the expert said. "What you get instead is… [TheTopNews] Read More.4 days ago
- Popular fruit may help protect your skin from the sun, new study suggestsThe benefits of grapes could go beyond providing a healthy snack.According to a study published in the journal ACS Nutrition Science, regular grape consumption can change how the genes behave, giving the skin an added defense system against sun damage.The research, led by scientists at Western New England University, suggests that grapes could trigger changes in DNA.EATING A COMMON VITAMIN-C PACKED FRUIT MIGHT TOTALLY TRANSFORM SKIN, STUDY FINDSResearchers tracked a group of volunteers who first followed a restricted diet for two weeks to clear their systems, according to a press release.Then, for the next two weeks, they ate the equivalent of three daily servings of whole grapes, provided in a concentrated, freeze-dried powder form.The scientists took small skin samples before and after the grape diet, testing them both under normal conditions and after exposing them to low doses of ultraviolet (UV) light from the sun.At the start of the study, each volunteer had their own pattern of gene activity. However, these patterns shifted noticeably after they ate grapes, after they were exposed to UV light, and when the grape-eating was combined with UV exposure.SUNLIGHT EXPOSURE CAN POSE LIFE-CHANGING HEALTH BENEFITS, EXPERT SAYSWhile everyone's individual genetic responses were unique, grape consumption changed gene expression across all participants.When skin is exposed to UV rays, it normally creates a chemical called malondialdehyde, which is a warning sign of cellular damage. After eating grapes, the volunteers showed significantly less of this damaging chemical, the study found."We are now certain that grapes act as a superfood and mediate a nutrigenomic response in humans," John Pezzuto, PhD, professor and dean of the College of Pharmacy and Health Sciences at Western New England University, said in the press release.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER"We observed this with the largest organ of the body, the skin. The changes in gene expression indicated improvements in skin health."CLICK HERE FOR MORE HEALTH STORIESPezzuto also noted that the benefits likely don't stop at the skin."Beyond skin, it is nearly certain that grape consumption affects gene expression in other somatic tissues of the body, such as the liver, muscles, kidney and even brain," he said.A major limitation of the study is its very small sample size, as usable, complete RNA sequencing data was successfully obtained from only four female participants, the researchers noted.TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZAdditionally, all four of these women shared a very similar skin… [TheTopNews] Read More.5 days ago
- Ozempic-style drugs linked to major slowdown in cancer spread, new study findsPopular GLP-1 (glucagon-like peptide-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference.Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers.The findings will be presented at the 2026 ASCO Annual Meeting next week in Chicago.WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALSAccording to a press release, the real-world retrospective study included 12,112 patients with the following types of obesity-related cancers, ranging from stage 1 to stage 3.Half of the participants started a GLP-1 medication – semaglutide, tirzepatide, dulaglutide, liraglutide, lixisenatide or pramlintide – after their cancer diagnosis.The other half began taking a DPP-4 inhibitor comparator ("gliptins"), a different class of diabetes medications, the study noted.WEIGHT-LOSS DRUGS’ IMPACT ON CANCER RISK REVEALED IN NEW STUDYCompared to the patients taking gliptins, the GLP-1 users were found to have significantly lower progression to stage 4 disease for four types of cancers.The biggest risk reduction was for non-small cell lung cancer (50%), followed by breast cancer (43%), colorectal cancer (31%) and liver cancer (38%)."Our study found that use of GLP-1 drugs, compared to DPP-4 inhibitors and other antidiabetic drugs, was associated with a meaningful reduction in cancer progression across four solid tumor types," said lead study author Mark David Orland, MD, of the Taussig Cancer Institute at Cleveland Clinic, in the release. "It provides early evidence that future studies are worth pursuing."CLICK HERE FOR MORE HEALTH STORIESThree other types of cancer – prostate, pancreatic and kidney – also had lower rates of spread among those taking GLP-1s, but those differences were "not statistically significant," the researchers noted.Tumors with higher levels of GLP-1 receptors — proteins that help cells respond to GLP-1 hormones and drugs — were also linked to better survival outcomes, according to the study findings.Overall, patients whose tumors had more of these receptors were about one-third less likely to die during the study period.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERThe incidence of adverse side effects were similar between GLP-1 and gliptin groups.The findings suggest that GLP-1 pathways may directly influence how some cancers grow or spread, though researchers say more studies are needed to understand the mechanism behind this effect.The study, which has not yet been peer-reviewed, had some limitations, according to the researchers. As it was… [TheTopNews] Read More.5 days ago
- One type of sitting may pose greater dementia risk than another, study suggestsFor years, researchers have believed prolonged sitting could raise dementia risk — but new findings suggest the type of sitting may matter more than previously thought.The research, which was published in the American Journal of Preventive Medicine in March, found that replacing mentally passive sedentary behavior with mentally active sedentary behavior was associated with a significant reduction in dementia risk.Mentally active sedentary behaviors could include reading, office work and other activities that keep the brain engaged while sitting, while mentally passive behaviors may include watching television or other low-engagement screen activities.'I'M A NEUROLOGIST — HERE'S WHY DEMENTIA IS RISING AND HOW TO REDUCE YOUR RISK’To gather the findings, Swedish researchers analyzed data from more than 20,000 adults between ages 35 and 64 who were tracked over a 19-year period, between 1997 and 2016, according to a press release.Participants answered questions about their sitting habits, physical activity and other lifestyle behaviors, while dementia diagnoses were identified using Swedish health and death records.Mentally active sedentary behavior was associated with "a significant reduction in dementia risk" compared to more passive sitting activities.CLICK HERE FOR MORE HEALTH STORIESAlthough the study was based in Sweden, the release said the findings "are likely generalizable to a wider global population" and could help "inform public health guidelines and preventive strategies to reduce dementia."In a statement, lead researcher Dr. Mats Hallgren of Sweden's Karolinska Institute said the study highlighted major distinctions between passive and mentally engaging sedentary habits when it comes to brain health."While all sitting involves minimal energy expenditure, it may be differentiated by the level of brain activity," said Hallgren.TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ"How we use our brains while we are sitting appears to be a crucial determinant of future cognitive functioning and, as we have shown, may predict dementia onset."CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERSedentary behavior is a "ubiquitous but modifiable risk factor for many health conditions, including dementia," according to the researcher."Our study adds the observation that not all sedentary behaviors are equivalent; some may increase the risk of dementia, while others may be protective," he added. "It is important to remain physically active as we age, but also mentally active — especially when we are sitting."The CDC projects that by 2060, nearly 14 million American adults will have Alzheimer's disease.One recent study published by the Alzheimer's Association found that a person's biological age may be tied to dementia… [TheTopNews] Read More.6 days ago
- Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, research...An investigational dementia drug may also ease alcohol withdrawal by calming the brain inflammation linked to addiction and relapse.That’s according to researchers at the University of Kentucky, who studied an experimental medication called MW150 that targets a brain inflammation pathway known as p38α MAPK.The drug, which has not yet been approved, is designed to treat mild to moderate Alzheimer’s disease.ALCOHOL DEATHS HAVE MORE THAN DOUBLED IN RECENT YEARS, ESPECIALLY AMONG WOMENScientists believe neuroinflammation may contribute to relapse risk and long-term neurological damage in people with alcohol use disorder.In laboratory and animal-model experiments, MW150 was found to reduce certain inflammatory markers during alcohol withdrawal.The work, which was published in the journal Alcohol, came from the University of Kentucky’s Sanders-Brown Center on Aging, led by neuroinflammation researcher Linda Van Eldik.ALCOHOL POSES THESE 8 RISKS TO OLDER ADULTS, EXPERTS WARNCaleb Bailey, PhD, co-author of the study and a researcher in Van Eldik’s lab, said the study provides "biological plausibility" that MW150 could mitigate neuroinflammation arising from alcohol withdrawal.Alcohol use disorder is difficult to treat because of high relapse rates, especially during withdrawal, according to Bailey."If follow-up experiments reveal similar anti-inflammatory effects of MW150 in animal models of alcohol use disorder, it would provide a strong rationale for development of MW150 as a treatment for those struggling with chronic alcohol relapse due to alcohol withdrawal," he told Fox News Digital.'I"M A NEUROSURGEON — HERE'S WHAT ALCOHOL DOES TO THE BODY'MW150, along with a related drug called Neflamapimod, is already being investigated in clinical trials as a potential therapy for dementia and other neurodegenerative conditions, the researchers noted."That gives this work added significance," Bailey said. "Because these compounds are already further along in development for other neurological diseases, it raises the possibility that they could someday be repurposed more efficiently for alcohol-related conditions if future studies continue to show promise."CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERThere were some important caveats of the research, including that it was conducted in cell culture and animal models."Because they are ‘dish’-based models, they provide limited information regarding what happens in the full organism – or even the full brain for that matter," Bailey said."A series of follow-up studies in living animals is required to more fully understand how future MW150 treatment in alcohol use and withdrawal affects systemic health and/or alcohol consumption."CLICK HERE FOR MORE HEALTH STORIESDr. Amy Swift, deputy chief medical officer at Silver Hill Hospital… [TheTopNews] Read More.6 days ago
The Searchable USWebDaily.com and TheTopNews NewsBank Helps You Be Better Informed, Faster! Spread The Word.
